丰原药业
(000153)
| 流通市值：28.67亿 | | | 总市值：28.90亿 |
| 流通股本：4.61亿 | | | 总股本：4.65亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,671,360,364.24 | 835,922,413.31 | 3,858,212,108.59 | 3,125,145,826.83 |
| 营业总成本 | 1,599,311,598.2 | 794,467,362.14 | 3,742,039,608.38 | 3,040,766,325.73 |
| 其他经营收益 | | | | |
| 营业利润 | 69,878,117.96 | 44,451,217.72 | 126,057,665.13 | 114,333,691.75 |
| 利润总额 | 74,696,067.72 | 44,435,428.76 | 125,179,614.41 | 113,949,975.44 |
| 净利润 | 70,277,823.39 | 36,434,372.64 | 94,804,169.89 | 98,215,098.62 |
| 每股收益 | | | | |
| 其他综合收益 | 29,826,607.58 | 40,302,903.55 | 21,085,740.01 | 24,669,992.92 |
| 综合收益总额 | 100,104,430.97 | 76,737,276.19 | 115,889,909.9 | 122,885,091.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,089,040,397.64 | 2,347,560,071.6 | 2,096,341,140.17 | 2,091,934,911 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,021,503,826.67 | 3,025,192,822.56 | 2,963,290,062.99 | 2,876,465,883.45 |
| 资产总计 | 5,110,544,224.31 | 5,372,752,894.16 | 5,059,631,203.16 | 4,968,400,794.45 |
| 流动负债: | | | | |
| 流动负债合计 | 2,470,221,482.46 | 2,615,828,352.43 | 2,376,437,194.26 | 2,305,082,322.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 456,317,966.7 | 552,994,973.31 | 557,193,734.11 | 537,345,793.34 |
| 负债合计 | 2,926,539,449.16 | 3,168,823,325.74 | 2,933,630,928.37 | 2,842,428,116.17 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,162,968,739.29 | 2,182,526,303.22 | 2,104,080,590.08 | 2,101,545,588.96 |
| 股东权益合计 | 2,184,004,775.15 | 2,203,929,568.42 | 2,126,000,274.79 | 2,125,972,678.28 |
| 负债和股东权益合计 | 5,110,544,224.31 | 5,372,752,894.16 | 5,059,631,203.16 | 4,968,400,794.45 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,769,102,040.18 | 911,949,897.13 | 4,052,684,933.64 | 2,547,419,301.37 |
| 经营活动现金流出小计 | 1,685,429,722.62 | 902,649,000.06 | 3,933,387,171.02 | 2,458,605,749.57 |
| 经营活动产生的现金流量净额 | 83,672,317.56 | 9,300,897.07 | 119,297,762.62 | 88,813,551.8 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 24,520.5 | 670 | 10,364,061.51 | 10,008,385.25 |
| 投资活动现金流出小计 | 39,054,628.89 | 30,116,799.8 | 280,605,804.57 | 165,372,565.71 |
| 投资活动产生的现金流量净额 | -39,030,108.39 | -30,116,129.8 | -270,241,743.06 | -155,364,180.46 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 961,917,291.65 | 520,746,994.03 | 1,534,129,075.21 | 967,314,958.53 |
| 筹资活动现金流出小计 | 664,540,449.52 | 286,482,111.69 | 1,471,010,301.68 | 881,523,519.68 |
| 筹资活动产生的现金流量净额 | 297,376,842.13 | 234,264,882.34 | 63,118,773.53 | 85,791,438.85 |
| 汇率变动对现金及现金等价物的影响 | -60,608.39 | -15,647.61 | -17,174.26 | -8,113.59 |
| 现金及现金等价物净增加额 | 341,958,442.91 | 213,434,002 | -87,842,381.17 | 19,232,696.6 |
| 期末现金及现金等价物余额 | 470,428,085.6 | 341,903,644.69 | 128,469,642.69 | 235,544,720.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 341,958,442.91 | - | -87,842,381.17 | - |